DEF: Ensign Group Seeks Stockholder Approval for Amended Incentive Plan and Director Elections at 2025 Annual Meeting

The Ensign Group is holding its 2025 Annual Meeting of Stockholders to vote on director elections, ratification of the accounting firm, executive compensation, and an amendment to the 2022 Omnibus Incentive Plan.

Summary

• The Ensign Group, Inc. is soliciting proxies for its 2025 Annual Meeting of Stockholders to be held on May 15, 2025.
• Key proposals include the election of four directors, ratification of Deloitte & Touche LLP as the independent accounting firm, an advisory vote on executive compensation, and approval of an amendment to the 2022 Omnibus Incentive Plan.
• The Board recommends voting FOR all director nominees and FOR Proposals 2, 3, and 4.
• The company highlights its strong 2024 performance, including increased same-facility occupancy to 81.3%, a 14.2% increase in consolidated revenue, and cash flow from operations of $347.2 million.
• The proposed amendment to the 2022 Omnibus Incentive Plan seeks to increase the number of shares authorized for issuance.
• The company emphasizes its commitment to corporate governance, risk oversight, and stakeholder engagement.

Sentiment

Score: 8

Explanation: The document expresses a positive outlook on the company's performance and future prospects, supported by strong financial results and strategic initiatives.

Positives

• Strong operational performance with increased occupancy and reduced agency usage.
• Significant revenue growth and strong cash flow generation.
• Continued payment and increase of dividends.
• Commitment to enhancing corporate governance practices.
• Active engagement with stockholders and focus on stakeholder value.
• Emphasis on environmental and social sustainability initiatives.
• Innovative approaches and strategic partnerships which supported multiple year growth in occupancy improvements and continue to enable the company to gain additional market share.

Risks

• Cybersecurity risks associated with information technology systems.
• Potential impact of changes in CMS star rating requirements on facility ratings.
• Dependence on attracting and retaining high-quality employees.
• Potential impact of economic conditions on the healthcare industry.

Future Outlook

When we consider the current health of our organization, combined with our culture and proven local leadership strategy, we are well-positioned to have another outstanding year in 2025.

Management Comments

• Our 2024 continued to be another outstanding year.
• Our local teams once again posted impressive clinical and financial results and continue to build remarkable momentum in each market across our portfolio while committing to clinical excellent care to our patients everyday.
• After another record year, we are excited about the many opportunities to continue to grow this effort by capturing the enormous upside in our portfolio as we relentlessly focus on the fundamentals across the organization.
• We are very proud by what we were able to accomplish in 2024.
• The results we achieved were possible due to the innovative approaches and strategic partnerships which supported our multiple year growth in occupancy improvements and continue to enable us to gain additional market share.
• These key initiatives together with our dedication to our cultural and operational fundamentals resulted in strong 2024 results.
• We also know there are so many opportunities in front of us to optimize operational efficiencies and drive occupancy and skilled mix as we continue to successfully unlock value and opportunity in the dozens of recently acquired operations.

Industry Context

The document references peer companies in the skilled nursing and healthcare REIT industries for director compensation benchmarking, indicating a competitive landscape for talent and resources.

Comparison to Industry Standards

• The Compensation Committee reviews the published director compensation information of other healthcare and real estate investment trust companies, including National Healthcare Corporation, Amedisys, Inc., Encompass Healthcare Corp., LTC Properties, Inc., Omega Healthcare Investors, Inc., Welltower Inc., Select Medical Holdings Corp., CareTrust REIT Inc., PACS Group, Inc., and National Health Investors, Inc.
• Based on these reviews, the Compensation Committee sets its annual retainers for outside directors and retainers to the chairpersons of each Board Committee at levels that we believe are comparable to the median cash compensation paid to directors of these companies.
• As of October 2024, despite the fact that Ensigns acquisition of facilities with 1 or 2-Star ratings skews our company-wide ratings, our mean score on the Five-Star Quality Rating System was 62.5%, which exceeds the national average score of 56.9%.
• Our average cycle 1 health inspections for all of our facilities, which is based on the latest inspections, is 20% better than the average results of the facilities in the states we operate in.

Related Party Transactions

• Clayton Christensen, brother of Executive Chairman, earned $1,141,109 in total cash compensation.
• Ryan Ross, brother-in-law of CIO, earned $318,304 in total compensation.
• Corwin Lewis, brother-in-law of COO, earned $800,857 in total compensation.

Stakeholder Impact

• Shareholders: The company's performance and governance practices aim to enhance long-term value.
• Employees: The incentive plan and compensation policies are designed to attract and retain talent.
• Patients: The company is committed to delivering high-quality healthcare services.
• Communities: The company aims to have an enduring impact through its core values and charitable activities.

Next Steps

• Stockholders to vote on proposals at the Annual Meeting on May 15, 2025.
• The company will continue to implement its business strategy and sustainability initiatives.
• The Compensation Committee will consider the outcome of the advisory vote on executive compensation when making future decisions.

Key Dates

Keywords

proxy statement, annual meeting, corporate governance, executive compensation, director election, incentive plan, financial performance, healthcare, skilled nursing, Deloitte & Touche LLP